000 01487nam a22002177a 4500
005 20260415090506.0
008 240113b |||||||| |||| 00| 0 eng d
020 _a9780857114419
050 _aAllied KJE 6201.A15
_bR85 2022
245 _aRules and guidance for pharmaceutical distributors 2022 /
_cMedicines & Healthcare products Regulatory Agency
264 _aU.K :
_bPharmaceutical Press ,
_c2022.
300 _axvii, 377 pages :
_c24 cm.
336 _2rdacontent
_atext
337 _2rdamedia
_aunmediated
338 _2rdacarrier
_avolume
500 _aIncludes index.
505 _aMedicines and healthcare products regulatory agency -- Wholesale distribution of medicines ; 2. UK legislation on wholesale distribution ; 3. EU guidelines on GDP and UK guidance on wholesale distribution -- Brokering of Medicines ; 4. UK legislation on brokering medicines ; 5. EU guidelines on GDP and UK guidance on brokering medicines -- Manufacture, importation and distribution of active substances ; 6. UK legislation on the manufacture, importation and distribution of active substances ; 7. Guidelines of 19 March 2015 on principles of good distribution practice of active substances for medicinal products for human use (2015/C 95/01) ; 8. UK guidance on the manufacture, importation and distribution of active substances.
650 _aDrugs
_xLaw and legislation
_zGreat Britain
650 _aDrugs
_xmarketing -Law & Legislation
_zGreat Britain
942 _2lcc
_cBK
_kEAC Cavite-Allied
999 _c94447
_d94447